Pregnancy Clinical Trial
Official title:
Behavioral and Environmental Factors and Time to Delivery
Verified date | July 13, 2009 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study, conducted at the Naval Medical Center in San Diego, CA, will determine if having
vaginal intercourse in the last weeks of pregnancy decreases the risk of having a prolonged
pregnancy. Pregnancies that continue beyond the due date may increase health risks for the
mother and the baby. Although some believe that vaginal intercourse can help start labor in
the last weeks of pregnancy, there is not proof that it works. Some studies showed that
sexual intercourse helped and some that pregnancy lasted even longer for couples having sex.
In addition to exploring the effect of sexual intercourse on time to delivery, this study
will collect information that can be used in the future to predict when labor will naturally
start and the risk for overdue pregnancies.
Women 18 years of age and older in their first pregnancy who are carrying a single fetus with
gestational age before 38 plus 6 weeks may be eligible for this study. Candidates must be
living with their partner in a stable relationship.
Participants are asked to have sexual intercourse about three times per week. They complete a
diary in which they record the times they have intercourse and how they are feeling daily.
The diaries are submitted by mail each week or at the doctor's or midwife's visit until
delivery. The women have a pelvic exam and ultrasound and complete questionnaires about
problems during pregnancy, overall well-being, attitude toward induction of labor, physical
activity, body image during pregnancy, stress and social support, habits at home, and
environmental conditions, such as weather.
Status | Completed |
Enrollment | 510 |
Est. completion date | July 13, 2009 |
Est. primary completion date | July 13, 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
- INCLUSION CRITERIA: 18 years or older Singleton pregnancy First birth Gestational age before 38 plus 6 weeks EXCLUSION CRITERIA: ART (IVF or ICSI) Maternal heart disease Gestational Diabetes, mellitus on insulin or pills Scheduled induction of labor or Cesarean section Breech presentation Placenta praevia Vaginal bleeding after 14 weeks of pregnancy Fetal growth restriction Known fetal anomalies (chromosomal or structural) Hospitalization after 14 weeks of pregnancy Can read and understand English Medical reasons for the patient not to have sex. Women whose husband/partner is currently deployed or will be deployed within the next four weeks or have any contra-indication for vaginal intercourse will be excluded. |
Country | Name | City | State |
---|---|---|---|
United States | Naval Medical Center, San Diego | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
United States,
Caughey AB, Musci TJ. Complications of term pregnancies beyond 37 weeks of gestation. Obstet Gynecol. 2004 Jan;103(1):57-62. — View Citation
Caughey AB, Stotland NE, Escobar GJ. What is the best measure of maternal complications of term pregnancy: ongoing pregnancies or pregnancies delivered? Am J Obstet Gynecol. 2003 Oct;189(4):1047-52. — View Citation
Caughey AB, Washington AE, Laros RK Jr. Neonatal complications of term pregnancy: rates by gestational age increase in a continuous, not threshold, fashion. Am J Obstet Gynecol. 2005 Jan;192(1):185-90. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to delivery | |||
Secondary | Rate of cesarean delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |